Doxepin
In 2016 the American College of Physicians advised that insomnia be treated first by treating comorbid conditions, then with cognitive behavioral therapy and behavioral changes, and then with drugs; doxepin was among those recommended for short-term help maintaining sleep, on the basis of weak evidence. The 2017 American Academy of Sleep Medicine recommendations focused on treatment with drugs were similar. A 2015 AHRQ review of treatments for insomnia had similar findings.
Somnoplasty
Somnoplasty, commonly known as Turbinate reduction surgery, (composed of the Latin root "somnus", meaning sleep, and the Greek word "plastia", meaning molding or formation) is a medical treatment approved by the Food and Drug Administration (FDA) to treat habitual snoring, chronic nasal obstruction, and obstructive sleep apnea (OSA) using radiofrequency ablation to shrink the tissues that are causing the problem. Somnoplasty is typically an outpatient procedure that takes 30-45 minutes.